PTC Therapeutics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
50.21 M |
Public Float |
38.91 M |
PTC Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.52 |
Market Cap |
$2.58 B |
Shares Outstanding |
58.43 M |
Public Float |
55.51 M |
Address |
100 Corporate Court South Plainfield New Jersey 07080 United States |
Employees | - |
Website | http://www.ptcbio.com |
Updated | 07/08/2019 |
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel medicines using its expertise in RNA biology. The company's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders and oncology. It is focused on developing treatments to fundamentally change the lives of patients living with rare genetic disorders. |